Abrey LE - Search Results

1

Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas.

Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, DeAngelis LM, Holland EC, Hormigo A. Iwamoto FM, et al. Among authors: abrey le. Neuro Oncol. 2011 Nov;13(11):1244-51. doi: 10.1093/neuonc/nor117. Epub 2011 Aug 10. Neuro Oncol. 2011. PMID: 21831900 Free PMC article.

2

Long-term survival in primary CNS lymphoma.

Abrey LE, DeAngelis LM, Yahalom J. Abrey LE, et al. J Clin Oncol. 1998 Mar;16(3):859-63. doi: 10.1200/JCO.1998.16.3.859. J Clin Oncol. 1998. PMID: 9508166

3

Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy.

Abrey LE, Rosenblum MK, DeAngelis LM. Abrey LE, et al. J Neurooncol. 1998 Sep;39(3):261-5. doi: 10.1023/a:1005958205591. J Neurooncol. 1998. PMID: 9821112 Review.

4

High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors.

Abrey LE, Rosenblum MK, Papadopoulos E, Childs BH, Finlay JL. Abrey LE, et al. J Neurooncol. 1999 Sep;44(2):147-53. doi: 10.1023/a:1006383400353. J Neurooncol. 1999. PMID: 10619498 Clinical Trial.

5

Treatment for primary CNS lymphoma: the next step.

Abrey LE, Yahalom J, DeAngelis LM. Abrey LE, et al. J Clin Oncol. 2000 Sep;18(17):3144-50. doi: 10.1200/JCO.2000.18.17.3144. J Clin Oncol. 2000. PMID: 10963643 Clinical Trial.

6

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Abrey LE, Olson JD, Raizer JJ, Mack M, Rodavitch A, Boutros DY, Malkin MG. Abrey LE, et al. J Neurooncol. 2001 Jul;53(3):259-65. doi: 10.1023/a:1012226718323. J Neurooncol. 2001. PMID: 11718258 Clinical Trial.

7

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.

Khan RB, Raizer JJ, Malkin MG, Bazylewicz KA, Abrey LE. Khan RB, et al. Among authors: abrey le. Neuro Oncol. 2002 Jan;4(1):39-43. doi: 10.1093/neuonc/4.1.39. Neuro Oncol. 2002. PMID: 11772431 Free PMC article. Clinical Trial.

8

High-grade gliomas in patients with prior systemic malignancies.

Maluf FC, DeAngelis LM, Raizer JJ, Abrey LE. Maluf FC, et al. Among authors: abrey le. Cancer. 2002 Jun 15;94(12):3219-24. doi: 10.1002/cncr.10595. Cancer. 2002. PMID: 12115354 Free article.

9

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

Khan RB, Shi W, Thaler HT, DeAngelis LM, Abrey LE. Khan RB, et al. Among authors: abrey le. J Neurooncol. 2002 Jun;58(2):175-8. doi: 10.1023/a:1016077907952. J Neurooncol. 2002. PMID: 12164690

10

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.

Abrey LE, Moskowitz CH, Mason WP, Crump M, Stewart D, Forsyth P, Paleologos N, Correa DD, Anderson ND, Caron D, Zelenetz A, Nimer SD, DeAngelis LM. Abrey LE, et al. J Clin Oncol. 2003 Nov 15;21(22):4151-6. doi: 10.1200/JCO.2003.05.024. J Clin Oncol. 2003. PMID: 14615443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters